- Home
- BYRN vs CYRX Comparison
BYRN vs CYRX Comparison
Compare BYRN & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BYRN | CYRX |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 416.1M | 438.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BYRN | CYRX |
|---|---|---|
| Price | $17.57 | $9.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $41.50 | $12.83 |
| AVG Volume (30 Days) | 298.1K | ★ 590.7K |
| Earning Date | 10-09-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 543.53 | N/A |
| EPS | 0.66 | ★ 1.27 |
| Revenue | $110,853,000.00 | ★ $243,795,000.00 |
| Revenue This Year | $39.65 | N/A |
| Revenue Next Year | $20.62 | $9.26 |
| P/E Ratio | $28.42 | ★ $7.43 |
| Revenue Growth | ★ 50.99 | 41.27 |
| 52 Week Low | $13.68 | $4.58 |
| 52 Week High | $34.78 | $11.44 |
Technical Indicators
Market Signals| Indicator | BYRN | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 39.60 | 48.15 |
| Support Level | $18.34 | $9.08 |
| Resistance Level | $19.50 | $10.30 |
| Average True Range (ATR) | 0.85 | 0.44 |
| MACD | 0.11 | 0.01 |
| Stochastic Oscillator | 15.68 | 16.13 |
Price Performance
Historical ComparisonAbout BYRN Byrna Technologies Inc.
Byrna Technologies Inc is a designer, manufacturer, retailer, and distributor of technological solutions for security situations that do not require the use of lethal force. The company generates its revenue from the United States, South Africa, Europe, South America, Asia, and Canada.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.